Invicta Diagnostic

Invicta Diagnostic

NSE SME

₹2,72,000 / Individual : 3200 Shares

Offer Date:Dec 1, 2025 - Dec 3, 2025
Listing Price : ₹50.4 at a Discount of 20%
Live
Share

IPO Live Subscription Details

CategorySubscription (Times)
Date
03 Dec 2025, 05:57 PM
QIBs
3.51 times
NII
7.27 times
Total
4.34 times

Invicta Diagnostic IPO Details

The Invicta Diagnostic IPO price band is set between ₹80-85 per equity share, with a face value of ₹10 per share. The issue is managed by Bigshare Services Pvt Ltd, and the equity shares are proposed to be listed on the NSE SME.

The IPO date for subscription opens on 1 Dec, 2025 and closes on 3 Dec, 2025. Investors can check the allotment status on 4 Dec, 2025, while the listing date is tentatively scheduled for 8 Dec, 2025.

The total issue size is 33,08,800 shares, aggregating up to ₹28.12 crore. Stay tuned for the latest Invicta Diagnostic IPO review and GMP updates.

Invicta Diagnostic IPO Review, Rating & Analysis

Invicta Diagnostic IPO Review

NO REVIEW

Invicta Diagnostic IPO Rating

Invicta Diagnostic IPO Highlights

IPO Date

Dec 1, 2025 - Dec 3, 2025

Listing Date

8 Dec, 2025

Face Value

₹10 Per Equity Share

Price Band

₹80-85 per equity share

Lot Size

-

Fresh Issue

Shares

Offer for Sale

-

Listing At

NSE SME

Invicta Diagnostic IPO Lot Size

The minimum market lot for Invicta Diagnostic IPO is 3200 shares with an application amount of ₹2,72,000. Retail investors can apply for up to 0 lots. The table below details the minimum and maximum investment limits for Retail and HNI investors.

ApplicationLotsSharesAmount
Retail (Min)13200₹2,72,000
Retail (Max)00₹0
S-HNI (Min)13200₹2,72,000
S-HNI (Max)39600₹8,16,000
B-HNI (Min)412800₹10,88,000

Invicta Diagnostic IPO Timeline

IPO Open Date
1 Dec, 2025
IPO Close Date
3 Dec, 2025
Basis of Allotment
4 Dec, 2025
Listing Date
8 Dec, 2025

Issue Price

₹80-85 per equity share

Face Value

₹10 Per Equity Share

Listing at Group

NSE SME

Registrar

Bigshare Services Pvt Ltd

Lead Manager

Socradamus Capital Pvt Ltd

Issue Size

33,08,800 shares(aggregating up to ₹28.12 crore)

Invicta Diagnostic IPO Financial Information

Period EndedAssetsRevenueProfit After TaxNet WorthReserves and SurplusTotal Borrowing
30-Sep-2534.9017.084.0823.6814.423.72
31-Mar-2521.2230.184.9313.605.183.54
31-Mar-2415.8915.903.818.678.543.81

In Cr.

Invicta Diagnostic IPO Reservation Details

Investor CategoryShares Offered% Shares
Anchor Investor Shares Offered79840024.13%
Market Maker Shares Offered1664005.03%
QIB Shares Offered53440016.15%
NII (HNI) Shares Offered54240016.39%
bNII > ₹10L3616009.39%
sNII < ₹10L1808004.85%
Individual Shares Offered126720038.3%
Total Shares Offered3308800100%

Invicta Diagnostic IPO Valuations

EPS Pre IPO

₹5.86/-

EPS Post IPO

₹6.50/-

PE Pre IPO

14.51

PE Post IPO

13.08

ROE

44.28%

ROCE

42.00%

Debt Equity

0.26

RoNW

36.25%

PAT Margin

16.38%

Price to Book Value

5.26

Promoters & Share Holding

Promoter(s) Name

  • Dr. Ketan Jayantilal Jain
  • Dr. Sanket Vinod Jain
  • Rohit Prakash Srivastava
  • Badal Kailash Naredi
  • Jayesh Prakash Jain
Share Holding Pre IssueShare Holding Post Issue
%%

About Company

Incorporated in January 2021, Invicta Diagnostic Limited offers radiology and pathology solutions. It provides pathology and radiology testing comprising imaging, radiology, pathology, and teleradiology services under the brand 'PC Diagnostics” through 7 diagnostic centres and a central laboratory across Mumbai in Maharashtra.

Invicta Diagnostics Limited, trading as PC Diagnostics, is a Mumbai-based diagnostic services company specializing in integrated pathology and radiology solutions. The company follows a hub‑and‑spoke model across the Mumbai Metropolitan Region, featuring:
A flagship hub offering full-spectrum pathology and advanced radiology (CT, MRI) at Thane West
Three other centres - Bhayandar, Byculla, Marol - offering specialized diagnostic services
Basic imaging, including X-ray and ultrasound, and sample collection were the focus of spokes at Lower Parel, Sewri, Mazgaon, and Kalwa.
It offers approximately 60 routine and 487 specialized pathology tests and around 96 basic and 130 advanced radiology investigations.

Invicta Diagnostics provides a comprehensive suite of diagnostic services that includes:
Routine Tests: Includes CBC, lipid profiles, liver function tests (LFT), kidney function tests (KFT), and thyroid panels
Specialized Tests: Molecular diagnostics, immunoassays, infectious disease markers including dengue, COVID-19, cancer markers, and genetic panels.

Sample Collection Network: Invicta uses phlebotomists and collection partners to reach patients at home or through its spoke centres. The company has a network of 5 laboratory doctors, 20 radiologists, and 127 well-trained technical staff as of May 31st, 2025. The company has 105 permanent employees as of May 31, 2025.

Read More

Invicta Diagnostic IPO Subscription Details

As onQIBNII
bNII  sNII
RetailTotal
Shares Offered / Reserved5,34,400
5,42,400

3,61,600    1,80,800
12,67,20023,44,000
Day 101-12-25 05:00 PM
1.00 x
0.68

0.79 x   0.45 x
0.28 x0.54 x
Day 202-12-25 05:00 PM
1.55 x
1.04

1.27 x   0.58 x
0.79 x1.02 x
Day 303-12-25 05:00 PM
3.51 x
7.27

7.76 x   6.27 x
3.44 x4.34 x
Total No. of Applications:1,772
Retail Subscription:

Retail:3.44x

BHNI:2.52x

SHNI:5.74x

Invicta Diagnostic IPO - Issue Objectives & Utilisation of proceeds

ObjectivesAmount
Funding capital expenditure for purchase of medical equipment towards establishment of five new diagnostic centres in Maharashtra-
General Corporate purposes-

Company Contact Details

Invicta Diagnostic

1 GF, Plot 217, Ambavat Bhavan, N.M Joshi Marg, Delisle Road, Mumbai, Maharashtra, 400013

Registrar Contact Details

Bigshare Services Pvt Ltd

Frequently Asked Questions about Invicta Diagnostic IPO

When will Invicta Diagnostic IPO open for subscription?

The Invicta Diagnostic IPO opens on 1 Dec, 2025 and closes on 3 Dec, 2025.

What is the investors portion for Invicta Diagnostic IPO?

The investors' portion for QIB is 3.51 x, NII is 7.76 x, and Retail is 3.44 x.

How to apply for Invicta Diagnostic IPO?

You can apply for Invicta Diagnostic IPO via ASBA online through your bank account. You can also apply via UPI through stock brokers like Zerodha, Upstox, or Paytm Money.

What is the issue size of Invicta Diagnostic IPO?

The issue size of Invicta Diagnostic IPO is approx ₹33,08,800 shares(aggregating up to ₹28.12 crore) crores.

What is the price band of Invicta Diagnostic IPO?

The price band for Invicta Diagnostic IPO is ₹80 to ₹85 per equity share.

What is the lot size of Invicta Diagnostic IPO?

The minimum bid (lot size) for Invicta Diagnostic IPO is 1600 shares with an investment of approx ₹2,72,000 .

What is the allotment date of Invicta Diagnostic IPO?

The allotment date for Invicta Diagnostic IPO is 4 Dec, 2025.

What is the listing date of Invicta Diagnostic IPO?

The listing date for Invicta Diagnostic IPO is expected to be 8 Dec, 2025.

What is the GMP of Invicta Diagnostic IPO?

The latest Grey Market Premium (GMP) for Invicta Diagnostic IPO is being updated regularly on IPOROCK.

PD

Parth D.

Founder & Lead Analyst

Parth D. is a software engineer and financial analyst who brings a quantitative edge to IPO tracking. With deep expertise in algorithmic trading and financial tool development, he builds the technology that powers IPORock's real-time data engines. He has been tracking the Indian market since 2018.

Invicta Diagnostic IPO Date, Review, Price, Allotment Details, GMP | IPOROCK